Immacolata Ruggiero Selected Research

diatomite

1/2016	Nanoparticle-based strategy for personalized B-cell lymphoma therapy.
12/2014	Diatomite biosilica nanocarriers for siRNA transport inside cancer cells.
1/2014	Diatomite silica nanoparticles for drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Immacolata Ruggiero Research Topics

Disease

4	Neoplasms (Cancer) 01/2015 - 08/2013
3	Lymphoma (Lymphomas) 01/2016 - 01/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016 - 01/2015
1	Leukemia 01/2016
1	Residual Neoplasm 01/2015

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2016 - 01/2015
3	diatomiteIBA 01/2016 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2016 - 12/2014
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Complement Factor B (Factor B)IBA 01/2016
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	Molecular Probes (Molecular Probe)IBA 04/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 12/2014
1	NanoconjugatesIBA 12/2014
1	Gemcitabine FDA Link 08/2013
1	raf KinasesIBA 08/2013
1	Interferon-alpha (Interferon Alfa)IBA 08/2013

Therapy/Procedure

2	Therapeutics 01/2016 - 01/2015
1	Radiotherapy 01/2015